Your browser doesn't support javascript.
loading
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features.
Benefield, Halei C; Reeder-Hayes, Katherine E; Nichols, Hazel B; Calhoun, Benjamin C; Love, Michael I; Kirk, Erin L; Geradts, Joseph; Hoadley, Katherine A; Cole, Stephen R; Earp, H Shelton; Olshan, Andrew F; Carey, Lisa A; Perou, Charles M; Troester, Melissa A.
Afiliación
  • Benefield HC; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Reeder-Hayes KE; Department of Medical Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Nichols HB; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Calhoun BC; Department of Pathology and Laboratory Medicine, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Love MI; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kirk EL; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Geradts J; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hoadley KA; Department of Pathology and Laboratory Medicine, East Carolina University, Greenville, NC, USA.
  • Cole SR; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Earp HS; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Olshan AF; Department of Medicine and Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Carey LA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Perou CM; Department of Medical Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Troester MA; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
JNCI Cancer Spectr ; 5(1)2021 Feb.
Article en En | MEDLINE | ID: mdl-33442657
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Población Negra / Población Blanca / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Aspecto: Determinantes_sociais_saude Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: JNCI Cancer Spectr Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Población Negra / Población Blanca / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Aspecto: Determinantes_sociais_saude Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: JNCI Cancer Spectr Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido